Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients-Reference-Cited by-同舟云学术

Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients

Published:2016-08-04 Issue:4 Volume:36 Page:1136-1139
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourol. Urodynam.

Author:

Noblett Karen¹,Benson Kevin²,Kreder Karl³

Affiliation:

1. University of California; Riverside California

2. Sanford Health; Sioux Falls South Dakota

3. University of Iowa; Iowa City Iowa

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/nau.23076/fullpdf

Reference9 articles.

1. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group;Schmidt;J Urol,1999

2. Sacral neuromodulation in the treatment of urgency-frequency symptoms: A multicenter study on efficacy and safety;Hassouna;J Urol,2000

3. Efficacy of sacral nerve stimulation for urinary retention: Results 18 months after implantation;Jonas;J Urol,2001

4. Sacral nerve stimulation for fecal incontinence: Results of a 120-patient prospective multicenter study;Wexner;Ann Surg,2010

5. Latest technologic and surgical developments in using InterStim therapy for sacral neuromodulation: Impact on treatment success and safety;Spinelli;Eur Urol,2008

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do Prophylactic Postoperative Antibiotics Prevent Sacral Neuromodulation Infections?;Urogynecology;2024-08-07

2. Treatment of the infected sacral nerve stimulator: A scoping review;Neurourology and Urodynamics;2024-02-06

3. Understanding a decade of safety reporting for sacral neuromodulation in the Food and Drug Administration Manufacturer and User Facility Device Experience database;Neurourology and Urodynamics;2023-07-27

4. The short-term false positives after sacral neuromodulation therapy: Who, how many and why? A prospective descriptive single centre study;Continence;2023-06

5. A novel sacral neuromodulation protocol is associated with reduction in removal for device infection;International Urogynecology Journal;2023-05-08